Droxidopa Capsule
Product Images NDC 67877-706

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 67877-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Droxi01 (Droxi01)

Chemical structure of the active ingredient Droxidopa, showing its molecular components including hydroxyl groups, an amino group, and a carboxyl group.*

FDA Label Image

Droxi02 (Droxi02)

A line graph showing mean change in dizziness over eight weeks during a double-blind treatment phase comparing Droxidopa and placebo groups. The x-axis represents weeks, and the y-axis shows the mean change in dizziness from baseline. Droxidopa shows a more pronounced reduction in dizziness over time compared to placebo, with a statistically significant difference indicated at week 1 (p<0.05). Error bars represent variability in data.*

FDA Label Image

Droxi03 (Droxi03)

A bar chart comparing the percent of subjects reporting improvement on OHSA Question 1 after treatment with Droxidopa versus placebo. The x-axis shows the scale of improvement from -8 (worse) to +8 (better), and the y-axis displays the percent of subjects. Droxidopa results are shown in black bars, and placebo results in white bars, illustrating the distribution of responses between the two groups.*

FDA Label Image

Droxidopa 100 mg 90s 1.jpg (Droxidopa 100 mg 90s 1)

Droxidopa Capsules 100 mg label showing the oral capsule dosage form. The label indicates 90 capsules per bottle and prescription use only. Manufactured by Alkem Laboratories and distributed by Ascend Laboratories, LLC. Includes directions for storage and cautionary warnings, along with an NDC number and barcode.*

FDA Label Image

Droxidopa 200 mg 90s.jpg (Droxidopa 200 mg 90s)

Droxidopa Capsules 200 mg oral capsules label displaying a 90-capsule package. The label includes storage instructions (20°C to 25°C, with excursions allowed), usage warnings, and prescribing information notes. Manufactured by Alkem Laboratories Ltd., Mumbai, India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. The label features the Ascend Laboratories logo and an NDC number 67877-705-90.*

FDA Label Image

Droxidopa 300 mg 90s.jpg (Droxidopa 300 mg 90s)

Label of Droxidopa Capsules 300 mg from Ascend Laboratories, LLC. The label states the product contains 90 capsules, is for oral use, and is prescription only. Storage instructions and warnings including to keep out of reach of children are provided. The manufacturer is Alkem Laboratories Ltd., Mumbai, India, and the distributor is Ascend Laboratories, LLC, Parsippany, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.